MBX Biosciences Common Stock (MBX) Selling, General & Administrative Expenses

Annual SG&A

$6.78 M
+$3.01 M+80.05%

01 December 2023

All-time High

$6.78 M
MBX annual selling, general & administrative expenses is currently at an all-time high
Annual Total Expenses$35.31 M
MBX annual total expenses is $35.31 million
Annual Operating Expenses$35.31 M
MBX annual total operating expenses is $35.31 million
Annual Net Income-$32.56 M
MBX annual net profit is -$32.56 million

MBX Selling, General & Administrative Expenses Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Quarterly SG&A

$2.87 M
0.00%

30 September 2024

All-time High

$2.87 M
MBX quarterly selling, general & administrative expenses is currently at an all-time high
Quarterly Total Expenses$19.61 M
MBX quarterly total expenses is $19.61 million
Quarterly Operating Expenses$19.61 M
MBX quarterly total operating expenses is $19.61 million
Quarterly Revenue$0.00
MBX quarterly revenue is $0.00
Quarterly Net Income-$18.14 M
MBX quarterly net profit is -$18.14 million

MBX Quarterly SG&A Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

TTM SG&A

-$301.28 M
-$121.92 M-67.97%

30 September 2024

All-time High

$2.87 M
MBX TTM selling, general & administrative expenses is currently <-9900.00% below its historical high of $2.87 million
Annual Total Expenses$35.31 M
MBX annual total expenses is $35.31 million
Annual Operating Expenses$35.31 M
MBX annual total operating expenses is $35.31 million
TTM Revenue$0.00
MBX TTM revenue is $0.00
TTM Net Income-$18.14 M
MBX TTM net profit is -$18.14 million

MBX TTM SG&A Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

MBX Selling, General & Administrative Expenses Performance

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year---
3 y3 years---
5 y5 years---

MBX Selling, General & Administrative Expenses High & Low

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3 years
5 y5 years
alltimeall timeat highat high<-9999.0%

MBX Biosciences Common Stock Selling, General & Administrative Expenses History

DateAnnualQuarterlyTTM
Sept 2024
-
$2.87 M(+53.0%)
$2.87 M(+53.0%)
Dec 2023
$6.78 M
-
-
DateAnnualQuarterlyTTM
Sept 2023
-
$1.87 M
$1.87 M
Dec 2022
$3.76 M
-
-

FAQ

  • What is MBX Biosciences Common Stock annual selling, general & administrative expenses?
  • What is the all time high annual SG&A for MBX Biosciences Common Stock?
  • What is MBX Biosciences Common Stock quarterly selling, general & administrative expenses?
  • What is the all time high quarterly SG&A for MBX Biosciences Common Stock?
  • What is MBX Biosciences Common Stock TTM selling, general & administrative expenses?
  • What is the all time high TTM SG&A for MBX Biosciences Common Stock?

What is MBX Biosciences Common Stock annual selling, general & administrative expenses?

The current annual SG&A of MBX is $6.78 M

What is the all time high annual SG&A for MBX Biosciences Common Stock?

MBX Biosciences Common Stock all-time high annual selling, general & administrative expenses is $6.78 M

What is MBX Biosciences Common Stock quarterly selling, general & administrative expenses?

The current quarterly SG&A of MBX is $2.87 M

What is the all time high quarterly SG&A for MBX Biosciences Common Stock?

MBX Biosciences Common Stock all-time high quarterly selling, general & administrative expenses is $2.87 M

What is MBX Biosciences Common Stock TTM selling, general & administrative expenses?

The current TTM SG&A of MBX is -$301.28 M

What is the all time high TTM SG&A for MBX Biosciences Common Stock?

MBX Biosciences Common Stock all-time high TTM selling, general & administrative expenses is $2.87 M